CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 3,220 enrolled
Drug / intervention
LNS-Zn5 +3 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00944281
NCT00944281N/ACompleted
CompareCT.gov

A Randomized, Double-blind, Controlled Trial in Rural Burkina Faso to Determine the Optimal Amount of Zinc to Include in a Lipid-based Nutrient Supplement (LNS). Part of the iLiNS Study

University of California, Davis·interventional·Posted Jul 23, 2009·Updated Jul 13, 2018

In Brief

A clinical study evaluating LNS-Zn5, LNS-Zn10, and 2 other interventions for Malnutrition. Completed, enrolled 3,220 participants across 1 site.

Detailed Summary

To assess zinc-related biochemical and functional responses among young Burkinabe children with a presumed high risk of zinc deficiency who receive micronutrient products containing different amounts of zinc, provided with or between meals.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMalnutrition
CountriesBurkina Faso
CollaboratorsUniversité Polytechnique de Bobo-Dioulasso

Timeline

N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedJul 23, 2009
Enrollment StartMay 1, 2010
Primary CompletionDec 1, 2014
TodayJul 2, 2026
Enrollment to primary: 4.6 yearsPosted 16.9 years ago

Interventions

LNS-Zn5dietary

Daily consumption of 20 g LNS containing 5 mg of zinc and daily placebo supplement

LNS-Zn10dietary

Daily consumption of 20 g LNS containing 10 mg of zinc and daily placebo supplement

LNS-Zn0dietary

20 g of LNS containing 0 mg of zinc and a daily placebo supplement

Suppl-Zn5dietary

Daily 5 mg zinc supplement ant consumption of 20 g LNS containing 0 mg of zinc